160 related articles for article (PubMed ID: 2068687)
41. [Modified lipoproteins--their types and role in atherogenesis].
Bratus' VV; Talaieva TV; Lomakovs'kyĭ OM; Tretiak IV; Radalovs'ka NV
Fiziol Zh (1994); 2000; 46(2):73-81. PubMed ID: 10867865
[TBL] [Abstract][Full Text] [Related]
42. [Clinico-hemodynamic evaluation of the efficacy of vasoactive and cardiotonic agents in the combined treatment of arteriosclerosis patients with chronic cerebral circulatory insufficiency].
Ishchenko MM; Dorogiĭ AN; Nechaĭ EE; Shkrobot SI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(9):1313-20. PubMed ID: 3425072
[TBL] [Abstract][Full Text] [Related]
43. [Mortality in men 40 to 59 years old from coronary and cerebral arteriosclerosis with varying cholesterol and triglyceride levels in the blood].
Nebieridze DV; Zhukovskiĭ GS; Akhmeteli MA; Gerasimova EN; Deev AD
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):78-81. PubMed ID: 7259871
[TBL] [Abstract][Full Text] [Related]
44. [Coagulation properties of the blood and effectiveness of heparin therapy in patients with the cerebral form of hypertension and atherosclerosis].
Mitsenko MD; Kukhtevich II; Mikhailiuk IA; Proskurkina OA; Rogova TS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(11):1613-9. PubMed ID: 1210939
[TBL] [Abstract][Full Text] [Related]
45. [Effect of complamin on the systemic and cerebral hemodynamics of atherosclerosis patients with chronic cerebral vascular disorders].
Ishchenko MM; Dorogiĭ AN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(1):59-65. PubMed ID: 3984595
[TBL] [Abstract][Full Text] [Related]
46. [Correction of microcirculation in patients with atherosclerotic lesions of different vessels by efferent methods].
Andozhskaia IuS
Vestn Khir Im I I Grek; 2007; 166(6):64-7. PubMed ID: 18411746
[TBL] [Abstract][Full Text] [Related]
47. [Use of the complex method of Il'k, Dodik and Iovanovich for diagnosis of humoral lipid disorders in coronary atherosclerosis].
Fomina LF; Sulava SG; Sulava PV
Ter Arkh; 1968 Jun; 40(6):61-3. PubMed ID: 5739211
[No Abstract] [Full Text] [Related]
48. [Genetic aspects of cerebral atherosclerosis and lipid metabolism].
Troshin VD; Kontorshchikova KN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(8):1126-32. PubMed ID: 6624335
[TBL] [Abstract][Full Text] [Related]
49. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
50. Lipoprotein abnormalities and extracoronary atherosclerosis in patients with premature ischemic heart disease.
Rubba P; Faccenda F; Iorio D; Pauciullo P; Cortese C; Spampinato N; Mancini M
Int Angiol; 1987; 6(4):331-7. PubMed ID: 3330114
[TBL] [Abstract][Full Text] [Related]
51. [The effect of pentoxifylline and nicergoline on the systemic and cerebral hemodynamics and on the blood rheological properties in patients with an ischemic stroke and atherosclerotic lesions of the major cerebral arteries].
Gara II
Zh Nevrol Psikhiatr Im S S Korsakova; 1993; 93(3):28-32. PubMed ID: 8042384
[TBL] [Abstract][Full Text] [Related]
52. Lipoprotein(a) in cerebrovascular and coronary atherosclerosis.
Nomura S
Hiroshima J Med Sci; 1995 Dec; 44(4):133-9. PubMed ID: 8857237
[TBL] [Abstract][Full Text] [Related]
53. [Phenotyping of hyperlipoproteinemias in atherosclerosis patients treated at Kislovodsk].
Shumskaia VI
Vopr Kurortol Fizioter Lech Fiz Kult; 1978; (3):33-6. PubMed ID: 149419
[No Abstract] [Full Text] [Related]
54. [Regression and therapy of atherosclerosis: regression of atherosclerosis under anti-cholesterol therapy].
Yamamoto A
Nihon Rinsho; 1988 Mar; 46(3):686-93. PubMed ID: 3404696
[No Abstract] [Full Text] [Related]
55. [Structural characteristics of dry blood serum of patients with arteriosclerosis after plasmapheresis].
Savina LV; Timofeeva LA
Fiziol Zh (1978); 1991; 37(3):43-8. PubMed ID: 1894050
[TBL] [Abstract][Full Text] [Related]
56. [Effect of a new Soviet-made antioxidant on the processes of lipid peroxidation in the treatment of patients with transient cerebro- vascular diseases and circulatory encephalopathy].
Lebedeva NV; Khrapova EV; Fedorova TN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(7):79-82. PubMed ID: 1661491
[TBL] [Abstract][Full Text] [Related]
57. [The use of glucuronyl-glucosamino-glycan sulfate (3GS) in the treatment of cerebral and peripheral athero-arteriosclerotic pathology].
Ciammaichella A; Solitro A; Torcia L; Arcuri P
Clin Ter; 1978 Mar; 84(5):509-21. PubMed ID: 648104
[No Abstract] [Full Text] [Related]
58. [The treatment of atherosclerosis and hypertension using extracorporeal therapy methods].
Malaia LT; Topchiĭ II; Volkov VI; Kondakov IK
Vestn Akad Med Nauk SSSR; 1991; (3):30-5. PubMed ID: 1882537
[TBL] [Abstract][Full Text] [Related]
59. A rationale for setting target plasma lipid levels to reverse atherosclerosis.
Parker TS; Saal SD; Gordon BR; Tyberg TI; Levine DM; Rubin AL
Beitr Infusionsther; 1988; 23():132-7. PubMed ID: 2484767
[No Abstract] [Full Text] [Related]
60. [Treatment of atherosclerosis with trilon B].
Nikitina EK; Abramova MA
Kardiologiia; 1972 Nov; 12(11):137-9. PubMed ID: 4632333
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
